The process of gathering information, verifying facts and assessing risks associated with a business transaction is called “due diligence”. A key challenge in any due diligence is how to gather, verify and evaluate this information within the time and budgetary constraints of the transaction.
Prior to embarking on any due diligence with an intellectual property (IP) component, it is useful if not imperative to understand the following:
- What is the nature of the transaction? Is it a license agreement, an acquisition, a merger, an investment or an IPO?
- Is there specific technology considered key to the deal? Is access to specific technology or a product line driving this deal?
- With respect to any key technology, where is it on the patent life cycle? Has it been patented? Is it an FDA approved product ? Is access to manufacturing key to the deal?
- Is the owner of the technology a publicly-traded company subject to the Sarbanes-Oxley Act of 2002?
- Is the market for the technology domestic or foreign, or both?
Read the complete article by clicking on the link below.
Author(s)
Related Insights
July 2, 2025
Energy Current
Has SCOTUS Pre-decided Whether the NRC Can License Private Off-Site High-Level Nuclear Waste Storage Facilities?
On June 18, 2025, the U.S. Supreme Court, in NRC v. Texas, issued an opinion holding that the State of Texas did not have standing to…
July 2, 2025
Health Care Law Today
AI-Powered Text Messaging by Digital Health Companies: Supreme Court Raises the Stakes
Digital health companies increasingly rely on AI-powered messaging platforms, chatbots, and virtual assistants to engage patients through…
July 2, 2025
Innovative Technology Insights
AI-Powered Text Messaging by Digital Health Companies: Supreme Court Raises the Stakes
Digital health companies increasingly rely on AI-powered messaging platforms, chatbots, and virtual assistants to engage patients through…